Article metrics

Download PDFPDF

O008/#785 A multicenter, open-label, randomized, phase 3 study to compare the efficacy and safety of lenvatinib in combination with pembrolizumab vs treatment of physician’s choice in patients with advanced endometrial cancer: study 309/keynote-775
Free

 

Online download statistics by month:

Online download statistics by month: November 2021 to March 2023

AbstractFullPdf
Nov 2021166051
Dec 2021235050
Jan 2022232050
Feb 202284021
Mar 2022119026
Apr 202247013
May 202265023
Jun 202257014
Jul 20223606
Aug 202263021
Sep 202256025
Oct 202249024
Nov 202264010
Dec 20223005
Jan 20233204
Feb 20232606
Mar 20234606
Total14070355